Drug · DIN 02412802
ADEMPAS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 25, 2013; first marketed September 25, 2013.
- Drug Identification Number (DIN)
- 02412802
- Company (DIN owner)
- Bayer Inc.Elkhart, Indiana, United States
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Riociguat C02KX05
- Class
- Human
- Record last updated
- June 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIOCIGUAT | 2 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 19, 2013: NOC 14748New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “adempas”. A notice may cover another product or only some lots: read it to see what it covers.
- ADEMPAS (riociguat) - New Contraindication for Patients with Pulmonary Hypertension Associated with Idiopathic Interstitial Pneumonias (PH-IIP)August 15, 2016 · Drugs · Product safety
Other DINs named ADEMPAS
- DIN 02412764 · Marketed
- DIN 02412772 · Marketed
- DIN 02412799 · Marketed
- DIN 02412810 · Marketed